[{"bibliography":"Aktipis, C.A., Boddy, A. M., Jansen, G., Hibner, U., Hochberg,\nM. E., Maley, C. C., & Wilkinson, G. S. , 2015, “Cancer\nacross the tree of life: cooperation and cheating in\nmulticellularity”, Philosophical Transactions of the Royal\nSociety B: Biological Sciences, 370(1673): 20140219."},{"bibliography":"Al-Hajj, M., & Clarke, M. F., 2004, “Self-renewal and\nsolid tumor stem cells”, Oncogene, 23(43):\n7274."},{"bibliography":"Aronowitz, R. A., 2007, Unnatural history: Breast cancer\nand American society, New York: Cambridge University Press."},{"bibliography":"–––, 2009, “The converged experience of\nrisk and disease”, The Milbank\nQuarterly, 87(2): 417–442."},{"bibliography":"–––, 2015, Risky medicine: our quest to cure\nfear and uncertainty, Chicago: University of Chicago Press."},{"bibliography":"Ashcroft, R., 2002, “What is clinical effectiveness?”,\nStudies in History and Philosophy of Science Part C: Studies in\nHistory and Philosophy of Biological and Biomedical\nSciences, 33(2): 219–233."},{"bibliography":"Bailey, Matthew H., Collin Tokheim, Eduard Porta-Pardo, Sohini\nSengupta, Denis Bertrand, Amila Weerasinghe, Antonio Colaprico, et al.,\n2018, “Comprehensive characterization of cancer driver genes and\nmutations”, Cell, 173(2): 371–385."},{"bibliography":"Bechtel, W., 2015, “Generalizing mechanistic explanations\nusing graph-theoretic representations”, in Explanation in\nBiology, P.A. Braillard & C. Malaterre (eds.), Dordrecht:\nSpringer. pp. 199–225."},{"bibliography":"–––, (forthcoming), “The importance of\nconstraints and control in biological mechanisms: Insights from cancer\nresearch” British Journal for the Philosophy of\nScience."},{"bibliography":"Bertolaso, M., 2009, “Towards an integrated view of the\nneoplastic phenomena in cancer research”, History and\nphilosophy of the life sciences, 31(1): 79–97."},{"bibliography":" –––, 2011, “The two sides of the\nhourglass: Analytic and synthetic approaches in cancer research”,\nLudus vitalis: revista de filosofía de las ciencias de la\nvida, 19(35): 73–95."},{"bibliography":"–––, 2011, “Hierarchies and causal\nrelationships in interpretative models of the neoplastic\nprocess”, History and philosophy of the life\nsciences, 33(4): 515–535."},{"bibliography":"–––, 2016, Philosophy of Cancer,\nDordrecht: Springer Science+ Business Media Dordrecht."},{"bibliography":"Bertolaso, M., and Dupré, J. (2018) “A processual\nperspective on cancer”, in Everything flows: towards a\nprocessual philosophy of biology, D.J. Nicholson &\nJ. Dupré (eds.), Oxford: Oxford University Press. pp.\n321–336."},{"bibliography":"Blasimme, A., Maugeri, P., & Germain, P. L. (2013). What\nmechanisms can’t do: Explanatory frameworks and the function of\nthe p53 gene in molecular oncology. Studies in History and\nPhilosophy of Science Part C: Studies in History and Philosophy of\nBiological and Biomedical Sciences, 44(3): 374–384"},{"bibliography":"Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia\nis organized as a hierarchy that originates from a primitive\nhematopoietic cell. Nature medicine, 3(7): 730."},{"bibliography":"Bouchard F, Huneman P (2013) From Groups to Individuals:\nPerspectives on Biological Associations and Emerging\nIndividuality, Cambridge, MA: MIT Press."},{"bibliography":"Bourret, P., Mogoutov, A., Julian-Reynier, C., & Cambrosio, A.\n(2006). A new clinical collective for French cancer genetics: A\nheterogeneous mapping analysis. Science, Technology, &\nHuman Values, 31(4): 431–464."},{"bibliography":"Boyd, Richard, 1999, “Homeostasis, Species, and Higher\nTaxa”, in Species—New Interdisciplinary Essays,\nR. Wilson (ed.), Cambridge: MIT Press, pp. 141–185."},{"bibliography":"Braillard, P. A., & Malaterre, C., 2015, Explanation in\nBiology: An Enquiry into the Diversity of Explanatory Patterns in the\nLife Sciences (Vol. 11). Dordrecht: Springer."},{"bibliography":"Broadbent, A., 2009, “Causation and models of disease in\nepidemiology”. Studies in History and Philosophy of\nScience Part C: Studies in History and Philosophy of Biological and\nBiomedical Sciences, 40(4): 302–311."},{"bibliography":"–––, 2014, “Disease as a theoretical\nconcept: The case of ‘HPV-itis’”, Studies in\nHistory and Philosophy of Science Part C: Studies in History and\nPhilosophy of Biological and Biomedical Sciences, 48(1):\n250–257."},{"bibliography":"Brown, M. J., 2013, “Values in science beyond\nunderdetermination and inductive risk”, Philosophy of\nScience, 80(5): 829–839."},{"bibliography":"Bueno, O., Chen R.-L., & Fagan, M.B. (eds.),\n2019, Individuation, Process, and Scientific\nPractices, Oxford, New York: Oxford University Press."},{"bibliography":"Cairns, J., 1975, “Mutation selection and the natural history\nof cancer”, Nature, 255(5505): 197."},{"bibliography":"Cancer Genome Atlas Network, 2015, “Comprehensive genomic\ncharacterization of head and neck squamous cell\ncarcinomas”, Nature, 517(7536): 576."},{"bibliography":"Cantor, D., 2018, “Cancer: Radical Surgery and the\nPatient”, in The Palgrave Handbook of the History of\nSurgery, pp. 457–477. London: Palgrave Macmillan."},{"bibliography":"Carter, K. C., 2003, The Rise of Causal Concepts of\nDisease: Case Histories, Aldershot: Ashgate."},{"bibliography":"Cartwright, N., 2011, “A philosopher's view of the long road\nfrom RCTs to effectiveness” The\nLancet, 377(9775): 1400–1401."},{"bibliography":"Clarke E., 2013, “The Multiple Realizability of Biological\nIndividuals”, Journal of Philosophy, 110(8):\n413–435."},{"bibliography":"–––, 2011, “The Problem of Biological\nIndividuality”, Biological Theory\n5(4):312–325"},{"bibliography":"Clarke, A. E., & Fujimura, J. H. (eds.), 2014, The\nright tools for the job: At work in twentieth-century life\nsciences, Princeton University Press."},{"bibliography":"Clevers, H., 2016, “Cancer therapy: defining stemness”,\n Nature, 534(7606): 176."},{"bibliography":"Collins, F. S., & Barker, A. D., 2007, “Mapping the\ncancer genome”, Scientific American, 296(3):\n50–57."},{"bibliography":"Craver, C. F., 2009, “Mechanisms and natural kinds”,\nPhilosophical Psychology, 22(5): 575–594."},{"bibliography":"Crespi, B., & Summers, K., 2005, “Evolutionary biology of\ncancer”, Trends in ecology &\nevolution, 20(10): 545–552."},{"bibliography":"Damuth J, Heisler IL, 1988, “Alternative formulations of\nmultilevel selection”, Biology and Philosophy,\n3:407–430."},{"bibliography":"Deaton, A., & Cartwright, N., 2018, “Understanding and\nmisunderstanding randomized controlled trials”, Social\nScience & Medicine, 210: 2–21."},{"bibliography":"Douglas, H., 2000, “Inductive risk and values in\nscience”, Philosophy of science, 67(4):\n559–579."},{"bibliography":"Dupré, J., 1995, The disorder of things: Metaphysical\nfoundations of the disunity of science, Cambridge, MA: Harvard\nUniversity Press."},{"bibliography":"Elliott, K. C., 2011, Is a little pollution good for you?:\nIncorporating societal values in environmental research, New\nYork: Oxford University Press USA."},{"bibliography":"Ereshefsky, M., 2009, “Defining ‘health’ and\n‘disease’”, Studies in History and Philosophy of\nScience Part C: Studies in History and Philosophy of Biological and\nBiomedical Sciences, 40(3): 221–227."},{"bibliography":"Ereshefsky, M., & Reydon, T. A., 2015, “Scientific\nkinds”, Philosophical Studies, 172(4):\n969–986."},{"bibliography":"Esserman, L. J., Thompson, I. M., Reid, B., Nelson, P., Ransohoff,\nD. F., Welch, H. G., … & Bissell, M., 2014,\n“Addressing overdiagnosis and overtreatment in cancer: a\nprescription for change”, The Lancet\noncology, 15(6): e234–e242."},{"bibliography":"Fagan, M., 2016, “Pathways to the clinic: cancer stem cells\nand challenges for translational research”, in G. Boniolo\n& M.J. Nathan (eds.), Philosophy of molecular medicine:\nFoundational issues in research and practice, New York: Taylor\n& Francis."},{"bibliography":"Fessler, E., & Medema, J. P., 2016, “Colorectal cancer\nsubtypes: developmental origin and microenvironmental\nregulation”, Trends in cancer, 2(9):\n505–518."},{"bibliography":"Foulds, L., 1958, “The natural history of cancer”,\nJournal of chronic diseases, 8(1): 2–37."},{"bibliography":"Frank, S. A., 2007, Dynamics of cancer: incidence, inheritance,\nand evolution, Princeton, NJ: Princeton University Press."},{"bibliography":"Fujimura, J. H., 1987, “Constructing ‘Do-able’\nProblems in Cancer Research: Articulating Alignment”,\nSoc. Stud. Science, 17(2): 257–293."},{"bibliography":"–––, 1996, Crafting science: A sociohistory\nof the quest for the genetics of cancer, Harvard University\nPress."},{"bibliography":"Germain, P-L. 2012, “Cancer Cells and Adaptive\nExplanations”, Biology and Philosophy 27\n(6):785–810."},{"bibliography":"–––, 2014, “Living instruments and\ntheoretical terms: Xenografts as measurements in cancer\nresearch”, in New Directions in the Philosophy of\nScience, pp. 141–155, Cham, Switzerland: Springer."},{"bibliography":"Germain, P. L., & Laplane, L. 2017, “Metastasis as\nsupra-cellular selection? A reply to Lean and\nPlutynski”, Biology & Philosophy, 32(2):\n281–287."},{"bibliography":"Godfrey-Smith, P. 2009, Darwinian populations and natural\nselection, Oxford: Oxford University Press."},{"bibliography":"González-Moreno, M., Saborido, C., & Teira, D. 2015,\n“Disease-mongering through clinical\ntrials”, Studies in History and Philosophy of Science\nPart C: Studies in History and Philosophy of Biological and Biomedical\nSciences, 51: 11–18."},{"bibliography":"Greaves, M., 2001, Cancer: the evolutionary legacy,\nOxford: Oxford University Press."},{"bibliography":"Greaves, M., & Maley, C. C., 2012, “Clonal evolution in\ncancer”, Nature, 481(7381): 306."},{"bibliography":"Green, S., forthcoming, “Is there a ‘right’ level\nor scale of analysis? Some lessons from cancer research”, in\nJ. diFrisco, D. Brooks, & W. Wimsatt (eds.), Hierarchy and\nLevels of Organization, The Vienna Series in Theoretical Biology,\nCambridge, MA: MIT Press."},{"bibliography":"Green, S. Serban, M. Scholl, Jones, N. Brigandt, I. and Bechtel,\nW., 2018, “Network analyses in systems biology: New strategies\nfor dealing with biological complexity”, Synthese,\n195:1751–1777"},{"bibliography":"Hanahan, D., & Weinberg, R. A., 2000, “The hallmarks of\ncancer”, Cell, 100(1): 57–70."},{"bibliography":"–––, 2011. “Hallmarks of cancer: the next\ngeneration”, Cell, 144(5): 646–674."},{"bibliography":"Hausman, D. M., 2012, “Health, naturalism, and functional\nefficiency”, Philosophy of Science, 79(4):\n519–541."},{"bibliography":"Hoadley, Katherine A., Christina Yau, Denise M. Wolf, Andrew D.\nCherniack, David Tamborero, Sam Ng, Max DM Leiserson, et al., 2014,\n“Multiplatform analysis of 12 cancer types reveals molecular\nclassification within and across tissues of origin”,\nCell 158(4): 929–944."},{"bibliography":"Hoadley, K. A., Yau, C., Hinoue, T., Wolf, D. M., Lazar, A. J.,\nDrill, E., … & Akbani, R., 2018, “Cell-of-origin\npatterns dominate the molecular classification of 10,000 tumors from 33\ntypes of cancer”, Cell, 173(2): 291–304."},{"bibliography":"Howick, J. H., 2011, The philosophy of evidence-based\nmedicine, Hoboken, NJ: John Wiley & Sons."},{"bibliography":"Khalidi, M.A.K., 1998, “Natural kinds and crosscutting\n\ncategories”, The Journal of Philosophy, 95(1):\n33–50."},{"bibliography":"–––, 2013, Natural categories and human\n\nkinds: Classification in the natural and social sciences,\nCambridge: Cambridge University Press."},{"bibliography":"Kincaid, H., 2008, “Do We Need Theory to Study Disease?:\nlessons from cancer research and their implications for mental\nillness”, Perspectives in biology and\nmedicine, 51(3): 367–378."},{"bibliography":"Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T.,\nCaceres-Cortes, J., … & Dick, J. E., 1994, “A cell\ninitiating human acute myeloid leukaemia after transplantation into\nSCID mice”, Nature, 367(6464): 645."},{"bibliography":"Laplane, L., 2018, “Cancer stem cells modulate patterns and\nprocesses of evolution in cancers”, Biology &\nPhilosophy, 33(3–4): 18."},{"bibliography":"–––, 2016, Cancer Stem\nCells, Cambridge, MA: Harvard University Press."},{"bibliography":"Laplane, L. and Solary, E. 2019. “Philosophy of Biology:\nTowards a classification of stem cells”, eLife 2019;8:e46563\nDOI: 10.7554/eLife.46563. "},{"bibliography":"Lean, C. and Plutynski, A., 2016. “The Evolution of Failure:\nExplaining Cancer as an Evolutionary Process”, Biology and\nPhilosophy 31(1): 39–57."},{"bibliography":"Love AC, Brigandt I., 2017, “Philosophical Dimensions of\nIndividuality”, in S. Lidgard and L.K. Nyhart (eds.), Biological\nIndividuality: Integrating Scientific, Philosophical, and Historical\nPerspectives, Chicago: University of Chicago Press."},{"bibliography":"Love, A. M. Travisano, K. Liu., 2017, “How Cancer Spreads:\nReconceptualizing a Disease”, in G. Boliolo & M. J. Nathan\n(eds.), Philosophy of Molecular Medicine: Foundational Issues in\nResearch and Practice, New York and London: Routledge. pp.\n100–121."},{"bibliography":"Löwy, I., 1996, Between bench and bedside: science,\nhealing, and interleukin-2 in a cancer ward, Cambridge, MA:\nHarvard University Press."},{"bibliography":"Machamer, P., Darden, L., & Craver, C. F., 2000,\n“Thinking about mechanisms”, Philosophy of\nScience, 67(1): 1–25."},{"bibliography":"Malaterre, C., 2007, “Organicism and reductionism in cancer\nresearch: Towards a systemic approach”, International\nStudies in the Philosophy of Science, 21(1): 57–73."},{"bibliography":"–––, 2011, “Making sense of Downward\nCausation in Manipulationism (with Illustrations from Cancer\nResearch)”, History and Philosophy of the Life\nSciences (33): 537–562."},{"bibliography":"Marcum, J. A., 2005, “Metaphysical presuppositions and\nscientific practices: Reductionism and organicism in cancer\nresearch”, International Studies in the Philosophy of\nScience, 19(1): 31–45."},{"bibliography":"Mariotto, A. B., Robin Yabroff, K., Shao, Y., Feuer, E. J., &\nBrown, M. L., 2011, “Projections of the cost of cancer care in\nthe United States: 2010–2020”, Journal of the\nNational Cancer Institute, 103(2): 117–128."},{"bibliography":"Martincorena, Iñigo, Amit Roshan, Moritz Gerstung, Peter\nEllis, Peter Van Loo, Stuart McLaren, David C. Wedge, et al. “High\nburden and pervasive positive selection of somatic mutations in normal\nhuman skin”, Science 348, no. 6237 (2015):\n880–886."},{"bibliography":"Maugeri, P. and Blasimme, A. 2011. “Humanized Models of\nCancer in Molecular Medicine: The Experimental Control of\nDisanalogy”, History and Philosophy of the Life\nSciences 33 (4): 603–621."},{"bibliography":"Mayo, D. G., & Hollander, R. D. (eds.),\n1994, Acceptable evidence: Science and values in risk\nmanagement, Oxford: Oxford University Press on Demand."},{"bibliography":"Mayo, D. G., & Spanos, A., 2006, “Philosophical scrutiny\nof evidence of risks: From bioethics to\nbioevidence”, Philosophy of Science, 73(5):\n803–816."},{"bibliography":"Merlo, L. M., Pepper, J. W., Reid, B. J., & Maley, C. C., 2006,\n“Cancer as an evolutionary and ecological\nprocess” Nature reviews cancer, 6(12):\n924–935."},{"bibliography":"Mitchell, S. D., 2009, Unsimple truths: Science,\ncomplexity, and policy, Chicago: University of Chicago Press."},{"bibliography":"Moss, L., 2004, What genes can't do, Cambridge, MA: MIT\nPress."},{"bibliography":"Morange, M., 1993, “The Discovery of Cellular\nOncogenes”, History and Philosophy of the Life Sciences,\n15(1): 45–58"},{"bibliography":"–––, 1997, “From the regulatory vision of\ncancer to the oncogene paradigm,\n1975–1985”, Journal of the History of\nBiology, 30(1): 1–29."},{"bibliography":"–––, 2003, “History of cancer\nresearch”, Encyclopedia of life sciences, London: Nature\nPublishing Group"},{"bibliography":"–––, 2007, “The field of cancer research:\nan indicator of present transformations in biology”,\nOncogene, 26(55): 7607–7610."},{"bibliography":"–––, 2015, “Is There an Explanation\nfor… the Diversity of Explanations in Biological\nStudies?”, in Braillard, P. A., C. Malaterre,\neds. Explanation in Biology: An Enquiry into the Diversity of\nExplanatory Patterns in the Life Sciences, Dordrecht: Springer,\npp. 31–46"},{"bibliography":"Nelson, C. M., & Bissell, M. J., 2006, “Of extracellular\nmatrix, scaffolds, and signaling: tissue architecture regulates\ndevelopment, homeostasis, and cancer”, Annu. Rev. Cell Dev.\nBiol., 22: 287–309."},{"bibliography":"Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E.,\nAlmeida, A. S., Ponz-Sarvise, M., … & Chio, I. I. C., 2017,\n“Distinct populations of inflammatory fibroblasts and\nmyofibroblasts in pancreatic cancer”, Journal of\nExperimental Medicine, 214(3): 579–596."},{"bibliography":"Okasha, S., 2005, “Multilevel selection and the major\ntransitions in evolution”, Philosophy of\nscience, 72(5): 1013–1025."},{"bibliography":"–––, 2006, Evolution and the\nlevels of selection, Oxford: Oxford University Press."},{"bibliography":"Oreskes, N., & Conway, E. M., 2011, Merchants of\ndoubt: How a handful of scientists obscured the truth on issues from\ntobacco smoke to global warming, New York: Bloomsbury Publishing\nUSA."},{"bibliography":"Pierce, G. B., & Speers, W. C., 1988, “Tumors as\ncaricatures of the process of tissue renewal: prospects for therapy by\ndirecting differentiation”, Cancer research, 48(8):\n1996–2004."},{"bibliography":"Plutynski, A. 2012, “Ethical Issues in Cancer Screening and\nPrevention”, Journal of Medicine and Philosophy 37\n(3):310–323."},{"bibliography":"–––, 2013, “Cancer and the Goals of\nIntegration”, History and Philosophy of Science Part\nC (4):466–476."},{"bibliography":"–––, 2017, “Safe or Sorry? Cancer\nScreening and Inductive Risk”, in Exploring Inductive\nRisk: Case Studies of Values in Science, K.C. Elliott &\nT. Richards (eds.), pp. 149–171."},{"bibliography":"–––, 2018, Explaining Cancer: \nFinding Order in Disorder, New York: Oxford University Press."},{"bibliography":"Pradeu, T., 2012, The Limits of the Self: Immunology and\nBiological Identity, New York: Oxford University Press."},{"bibliography":"–––, 2013, “Immunity and the\nemergence of individuality” in From Groups to Individuals:\nEvolution and Emerging Individuality, F. Bouchard and P. Huneman (eds.),\nCambridge, MA: MIT Press, pp 77–96"},{"bibliography":"–––, 2016, “The many faces of\nbiological individuality”, Biology and Philosophy,\n31:761–773."},{"bibliography":"–––, forthcoming, Philosophy of\nImmunology: Understanding the Central Role of the Immune System in\nToday’s Biology and Medicine, Cambridge: Cambridge\nUniversity Press."},{"bibliography":"Prasad, V., & Gale, R. P., 2016, “Precision medicine in\nacute myeloid leukemia: Hope, hype or both?”, Leukemia\nresearch, 48: 73–77."},{"bibliography":"Prasad, V., Fojo, T., & Brada, M., 2016, “Precision\noncology: origins, optimism, and potential” The Lancet\nOncology, 17(2): e81–e86."},{"bibliography":"Proctor, R. N., 1996, Cancer Wars: How Politics Shapes What We\nKnow and Don’t Know About Cancer, New York: Basic\nBooks."},{"bibliography":"Reid, L., 2017, “Truth or Spin? Disease Definition in\nCancer Screening”, Journal of Medicine and Philosophy: A\nForum for Bioethics and Philosophy of Medicine 42\n(4):385–404."},{"bibliography":"Reiss, J., 2010, “In favour of a Millian proposal to reform\nbiomedical research”, Synthese, 177(3):\n427–447."},{"bibliography":"–––, 2015, “A pragmatist theory of\nevidence”, Philosophy of Science, 82(3): 341–362."},{"bibliography":"Reiss, J., and Kitcher, P., 2009, Biomedical research, neglected\ndiseases, and well-ordered science. THEORIA. Revista de\nTeoría, Historia y Fundamentos de la Ciencia,\n24(3): 263–282."},{"bibliography":"Schedin, P., 2006, “Pregnancy-associated breast cancer and\nmetastasis”, Nature Reviews Cancer, 6(4):\n281."},{"bibliography":"Schwartz, P. H., 2007, “Defining dysfunction: Natural\nselection, design, and drawing a line”, Philosophy of\nScience, 74(3): 364–385."},{"bibliography":"–––, 2008, “Risk and disease”,\n Perspectives in Biology and Medicine, 51(3):\n320–334."},{"bibliography":"–––, 2014, “Small tumors as risk\nfactors not disease”, Philosophy of\nScience, 81(5): 986–998."},{"bibliography":"Shrader-Frechette, K. S., 1993, Burying uncertainty: Risk\nand the case against geological disposal of nuclear waste, San\nFrancisco: University of California Press."},{"bibliography":"–––, 2002, Environmental justice:\nCreating equality, reclaiming democracy, New York: Oxford\nUniversity Press."},{"bibliography":"–––, 2007, Taking action, saving lives:\nour duties to protect environmental and public health, New York:\nOxford University Press."},{"bibliography":"–––, 2012, Risk analysis and scientific\nmethod: Methodological and ethical problems with evaluating societal\nhazards, Netherlands: Springer Science & Business Media."},{"bibliography":"Siegel, R. L., Miller, K. D., & Jemal, A., 2017, “Cancer\nstatistics, 2017”, CA: a cancer journal for clinicians,\n67(1): 7–30"},{"bibliography":"Slater, M. H., 2014, “Natural kindness”, The\nBritish Journal for the Philosophy of Science, 66(2):\n375–411."},{"bibliography":"Solomon, M., 2015, Making medical knowledge, New\nYork: Oxford University Press, USA."},{"bibliography":"Solomon, M., Simon, J. R., & Kincaid, H. (eds.).,\n2016, The Routledge companion to philosophy of medicine,\nNew York: Taylor & Francis."},{"bibliography":"Sorenson, R., 2011, “Paranatural Kinds” in Carving\nNature at Its Joints: Natural Kinds in Metaphysics and Science,\nJ. K. Campbell, M. O'Rourke, & M. H. Slater (eds.), Cambridge,\nMA: MIT Press. 113–128."},{"bibliography":"Soto, A. M., & Sonnenschein, C., 2012, “Is systems\nbiology a promising approach to resolve controversies in cancer\nresearch?”, Cancer cell international, 12(1):\n1–5."},{"bibliography":"–––, 2004, “The somatic mutation\ntheory of cancer: growing problems with the\nparadigm?”, Bioessays, 26(10): 1097–1107."},{"bibliography":"–––, 2005, “Emergentism as a default:\ncancer as a problem of tissue organization”, Journal of\nBiosciences, 30(1): 103–11"},{"bibliography":"Steel, D., 2007, Across the boundaries: Extrapolation in\nbiology and social science, Oxford: Oxford University Press."},{"bibliography":"–––, 2010, “Epistemic values and the\nargument from inductive risk”, Philosophy of\nScience, 77(1): 14–34."},{"bibliography":"–––, 2015, Philosophy and the\nprecautionary principle, New York: Cambridge University\nPress."},{"bibliography":"Stegenga, J., 2015, “Measuring\neffectiveness”, Studies in History and Philosophy of\nScience Part C: Studies in History and Philosophy of Biological and\nBiomedical Sciences, 54: 62–71."},{"bibliography":"–––, 2018, Medical Nihilism,\nOxford: Oxford University Press."},{"bibliography":"Teira, D., & Reiss, J., 2013, “Causality, impartiality\nand evidence-based policy”, in Mechanism and causality\nin biology and economics Illari, P., Russo, F., and\nWilliamson, J., eds., Dordrecht: Springer, pp. 207–224."},{"bibliography":"Weinberg, R., 2013, The Biology of Cancer, New York:\nGarland science."},{"bibliography":"Weaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand,\nP., Damsky, C., & Bissell, M. J., 1997, “Reversion of the\nmalignant phenotype of human breast cells in three-dimensional culture\nand in vivo by integrin blocking antibodies”, The\nJournal of cell biology, 137(1): 231–245."},{"bibliography":"Weaver, V. M., Lelièvre, S., Lakins, J. N., Chrenek, M. A.,\nJones, J. C., Giancotti, F., … & Bissell, M. J., 2002,\n“β4 integrin-dependent formation of polarized\nthree-dimensional architecture confers resistance to apoptosis in\nnormal and malignant mammary epithelium”, Cancer\ncell, 2(3): 205–216."},{"bibliography":"Williams, Neil E., 2011, “Arthritis and nature’s\njoints”, in Carving Nature at Its Joints: Natural Kinds in\nMetaphysics and Science, Joseph Keim Campbell, Michael O'Rourke, \n& Matthew H. Slater (eds.), Cambridge, MA: MIT Press, pp.\n199–230."},{"bibliography":"Zheng, Siyuan, Andrew D. Cherniack, Ninad Dewal, Richard A.\nMoffitt, Ludmila Danilova, Bradley A. Murray, Antonio M. Lerario, et al.,\n2016, “Comprehensive pan-genomic characterization of adrenocortical\ncarcinoma”, Cancer cell, 2995: 723–736."}]
